Lilly: Put law enforcement on the online fakes case

Eli Lilly is asking law enforcement to backtrack the online counterfeit drug supply chain and shut down the sources. Getting to the source of fakes is one element of the company's brand-protection strategy.

"Dismantling counterfeit pharmaceutical networks must become a higher priority for law enforcement globally," said Michael Russo, director of global security at Eli Lilly, as in-Pharma Technologist reports.

Companies that indirectly support fake pharmacies is another of the drug giant's targets.

The article notes that Google and Go Daddy are setting up the non-profit Center for Safe Internet Pharmacies. But government support is needed to provide legal protection, allowing the center to terminate service to sites that endanger public health.

- here's the story

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.